Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · IEX Real-Time Price · USD
9.93
+0.03 (0.30%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Olema Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for OLMA stock have an average target of 21.8, with a low estimate of 19 and a high estimate of 25. The average target predicts an increase of 119.54% from the current stock price of 9.93.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OLMA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +141.69% | Apr 2, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $21 | Buy | Reiterates | $21 | +111.48% | Mar 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +151.76% | Mar 12, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +101.41% | Jan 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +181.97% | Oct 11, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.41
from -2.14
EPS Next Year
-2.68
from -2.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 23.6M | 163.8M | 567.6M |
| Avg | n/a | n/a | 7.8M | 65.8M | 306.5M |
| Low | n/a | n/a | n/a | 21.7M | 68.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 2,000.0% | 762.9% |
| Avg | - | - | - | 743.3% | 366.0% |
| Low | - | - | - | 177.7% | 4.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.39 | -2.53 | -2.51 | -0.97 | 4.28 |
| Avg | -2.41 | -2.68 | -2.71 | -1.92 | 1.14 |
| Low | -2.36 | -2.94 | -3.04 | -2.58 | -1.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.